Stellman S D, Takezaki T, Wang L, Chen Y, Citron M L, Djordjevic M V, Harlap S, Muscat J E, Neugut A I, Wynder E L, Ogawa H, Tajima K, Aoki K
Division of Epidemiology, American Health Foundation, Valhalla, New York 10595, USA.
Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1193-9.
Rates of lung cancer in American men have greatly exceeded those in Japanese men for several decades despite the higher smoking prevalence in Japanese men. It is not known whether the relative risk of lung cancer associated with cigarette smoking is lower in Japanese men than American men and whether these risks vary by the amount and duration of smoking. To estimate smoking-specific relative risks for lung cancer in men, a multicentric case-control study was carried out in New York City, Washington, DC, and Nagoya, Japan from 1992 to 1998. A total of 371 cases and 373 age-matched controls were interviewed in United States hospitals and 410 cases and 252 hospital controls in Japanese hospitals; 411 Japanese age-matched healthy controls were also randomly selected from electoral rolls. The odds ratio (OR) for lung cancer in current United States smokers relative to nonsmokers was 40.4 [95% confidence interval (CI) = 21.8-79.6], which was >10 times higher than the OR of 3.5 for current smokers in Japanese relative to hospital controls (95% CI = 1.6-7.5) and six times higher than in Japanese relative to community controls (OR = 6.3; 95% CI = 3.7-10.9). There were no substantial differences in the mean number of years of smoking or average daily number of cigarettes smoked between United States and Japanese cases or between United States and Japanese controls, but American cases began smoking on average 2.5 years earlier than Japanese cases. The risk of lung cancer associated with cigarette smoking was substantially higher in United States than in Japanese males, consistent with population-based statistics on smoking prevalence and lung cancer incidence. Possible explanations for this difference in risk include a more toxic cigarette formulation of American manufactured cigarettes as evidenced by higher concentrations of tobacco-specific nitrosamines in both tobacco and mainstream smoke, the much wider use of activated charcoal in the filters of Japanese than in American cigarettes, as well as documented differences in genetic susceptibility and lifestyle factors other than smoking.
几十年来,美国男性的肺癌发病率大大超过了日本男性,尽管日本男性的吸烟率更高。尚不清楚与吸烟相关的肺癌相对风险在日本男性中是否低于美国男性,以及这些风险是否因吸烟量和吸烟持续时间而异。为了估计男性中特定吸烟量的肺癌相对风险,1992年至1998年在纽约市、华盛顿特区和日本名古屋开展了一项多中心病例对照研究。在美国医院对371例病例和373例年龄匹配的对照进行了访谈,在日本医院对410例病例和252例医院对照进行了访谈;还从选民名单中随机选取了411名年龄匹配的日本健康对照。美国当前吸烟者相对于不吸烟者的肺癌比值比(OR)为40.4[95%置信区间(CI)=21.8-79.6],这比日本当前吸烟者相对于医院对照的OR值3.5(95%CI=1.6-7.5)高出10倍以上,比日本当前吸烟者相对于社区对照的OR值(OR=6.3;95%CI=3.7-10.9)高出6倍。美国和日本的病例之间以及美国和日本的对照之间,平均吸烟年数或平均每日吸烟量没有实质性差异,但美国病例开始吸烟的平均时间比日本病例早2.5年。与吸烟相关的肺癌风险在美国男性中显著高于日本男性,这与基于人群的吸烟率和肺癌发病率统计数据一致。这种风险差异的可能解释包括美国生产的香烟的毒性更大,这可从烟草和主流烟雾中更高浓度的烟草特异性亚硝胺得到证明;日本香烟过滤嘴中活性炭的使用比美国香烟广泛得多;以及除吸烟外,在遗传易感性和生活方式因素方面已记录的差异。